Skip to main content
Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd. — Investor Relations & Filings

Ticker · ENLV ISIN · IL0011319527 TA Manufacturing
Open in API
Filings indexed 485 across all filing types
Latest filing 2023-04-19 Regulatory Filings
Country IL Israel
Listing TA ENLV

About Enlivex Therapeutics Ltd.

https://enlivex.com/

Enlivex Therapeutics Ltd. is a clinical-stage macrophage reprogramming immunotherapy company. It is focused on developing Allocetra™, a universal, off-the-shelf cell therapy designed to treat immune system dysregulation. The therapy works by reprogramming macrophages to resolve hyper-inflammation. Enlivex is evaluating Allocetra™ in clinical trials for the treatment of multiple indications, including acute inflammatory diseases such as sepsis and chronic inflammatory conditions like osteoarthritis. The product candidate offers flexible administration options, including systemic intravenous infusion and targeted local injections.

Recent filings

Filing Released Lang Actions
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
Regulatory Filings Classification · 1% confidence The document explicitly states it is a "Form 6-K" filed with the SEC by a Foreign Private Issuer for the month of April 2023. Form 6-K is used to report material information that a foreign private issuer is required to disclose to its home country's stock exchange or make public in its home country, or information that it furnishes to the SEC. This type of filing is generally used to attach press releases or other material updates that do not fit neatly into standard US periodic reports (like 10-K or 10-Q). The content is a press release announcing a Notice of Allowance for a U.S. Patent. Since Form 6-K is a general reporting mechanism for foreign issuers and the content is a specific, material announcement (patent allowance), it does not fit the definitions for 10-K (Annual Report), ER (Earnings Release), or IR (Interim Report). Given the options, the most appropriate general category for a non-standard, material regulatory filing that isn't covered by a more specific code (like DIRS, DIV, or CAP) is the general regulatory filing fallback category, RNS (Regulatory Filings), which often encompasses 6-K filings that are essentially press release disclosures. However, looking closely at the provided definitions, RNS is defined as "General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories." While 6-K is a specific form, its function here is to disseminate a press release. If a more specific category existed for 6-K filings, that would be preferred. Since it is a regulatory filing that doesn't match the specific content types (like DIRS, DIV, etc.), RNS is the best fit among the choices provided for a miscellaneous SEC filing.
2023-04-19 English
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
Report Publication Announcement Classification · 1% confidence The document is very short (1771 characters) and explicitly states, "Attached hereto is a report on *6-k* *6k19042023_DC_isa.pdf*". This structure indicates that the document itself is an announcement about the publication of another report (a Form 6-K, which is a general report for foreign private issuers, often filed with the SEC, but here being reported to the Israel Securities Authority and Tel Aviv Stock Exchange). According to Rule 2, when a document is short and announces the attachment or publication of a report, it should be classified as a Report Publication Announcement (RPA). Since '6-K' is a general regulatory filing, RPA is the most appropriate classification based on the document's function as a notification of publication.
2023-04-19 English
Appoints Andrew Singer to its Board of Directors
Board/Management Information Classification · 1% confidence The document is explicitly identified as a "Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934". Form 6-K filings are used by foreign private issuers to report material information that they are required to disclose to their home country's securities regulator or stock exchange, or that they make public in their home country. The content of this specific 6-K announces the appointment of a new member to the Board of Directors, which is a material event concerning management/board structure. While the content relates to Board/Management Information (MANG), the primary classification must reflect the regulatory filing type itself. Since Form 6-K is a general, periodic, or event-driven filing for foreign issuers that doesn't map directly to the specific US forms (like 10-K or DEF 14A), and it reports a specific corporate event (board change), the most appropriate general category among the provided options that covers miscellaneous regulatory announcements not fitting elsewhere is 'Regulatory Filings' (RNS), or if we strictly interpret the content, it strongly aligns with 'Board/Management Information' (MANG). Given the explicit mention of the SEC form (6-K) and the nature of the announcement (new director appointment), MANG is the most specific content-based classification, as 6-K filings often serve as the vehicle for such announcements. However, looking at the definitions, MANG is for 'Announcement of changes in the company's board of directors or senior management.' This document is exactly that, filed on a Form 6-K. I will classify it as MANG based on the content focus, as 6-K is a vehicle, not the content type itself, and MANG is a defined category for this specific event.
2023-04-17 English
Appoints Andrew Singer to its Board of Directors
Report Publication Announcement Classification · 1% confidence The document is very short (1771 characters) and explicitly states, "Attached hereto is a report on *6-k* *6k17042023_DC_isa.pdf*". This structure indicates that the document itself is an announcement about the publication of another report (a 6-K filing, which is an SEC filing for foreign private issuers, often used for material events). According to Rule 2, when a document is short and announces the availability of a report, it should be classified as a Report Publication Announcement (RPA). Since this is an announcement of a filing, RPA is the most appropriate classification over the underlying filing type (which would typically be RNS or potentially 10-K/IR if it were the full report).
2023-04-17 English
FORM 20-F For the fiscal year ended December 31, 2022
Annual Report Classification · 1% confidence The document is a Form 20-F filed with the U.S. Securities and Exchange Commission (SEC). Form 20-F is the standard annual report filing for foreign private issuers, equivalent to the 10-K for domestic U.S. companies. The text explicitly identifies itself as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2022. Therefore, it is classified as a 10-K. FY 2022
2023-04-10 English
FORM 20-F For the fiscal year ended December 31, 2022
Report Publication Announcement Classification · 1% confidence The document explicitly states it is a "Report of Periodic or Interim Report" filed under Regulation 3 concerning a "Foreign Corporation." It mentions attaching a report named "*20F*" and provides the filename "*20F10042023_8_DC_isa.pdf*". The Form 20-F is the standard annual report filed by foreign private issuers with the SEC. Since this document is an announcement *about* the filing of the 20-F, and given the context of Israeli regulatory bodies (ISA, TASE) and the short length (1889 chars), it fits the description of a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) itself. However, the 20-F is the foreign equivalent of the 10-K. Given the options, and the fact that it is a comprehensive annual filing being announced, the closest fit for the *content* being referenced is the Annual Report (10-K), but the *document type* itself is an announcement. Since there is no specific code for '20-F Announcement', and RPA is for announcing the publication of reports, RPA is the most accurate classification based on the 'MENU VS MEAL' rule, as this is a cover sheet announcing the attached report.
2023-04-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.